Table of Contents

April 01 1998; volume 47 issue 4

You have accessRestricted Access
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
B M Spiegelman

Diabetes 1998 Apr; 47 (4): 507-514. https://doi.org/10.2337/diabetes.47.4.507

Add to Selected Citations
You have accessRestricted Access
Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.
L S Liu, M Spelleken, K Röhrig, H Hauner and J Eckel

Diabetes 1998 Apr; 47 (4): 515-522. https://doi.org/10.2337/diabetes.47.4.515

Add to Selected Citations
You have accessRestricted Access
Basal hepatic glucose production is regulated by the portal vein insulin concentration.
D K Sindelar, C A Chu, P Venson, E P Donahue, D W Neal and A D Cherrington

Diabetes 1998 Apr; 47 (4): 523-529. https://doi.org/10.2337/diabetes.47.4.523

Add to Selected Citations
You have accessRestricted Access
Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
M Tang-Christensen, N Vrang and P J Larsen

Diabetes 1998 Apr; 47 (4): 530-537. https://doi.org/10.2337/diabetes.47.4.530

Add to Selected Citations
You have accessRestricted Access
Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting.
D G Baskin, R J Seeley, J L Kuijper, S Lok, D S Weigle, J C Erickson, R D Palmiter and M W Schwartz

Diabetes 1998 Apr; 47 (4): 538-543. https://doi.org/10.2337/diabetes.47.4.538

Add to Selected Citations
You have accessRestricted Access
Physiological insulinemia acutely modulates plasma leptin.
M F Saad, A Khan, A Sharma, R Michael, M G Riad-Gabriel, R Boyadjian, S D Jinagouda, G M Steil and V Kamdar

Diabetes 1998 Apr; 47 (4): 544-549. https://doi.org/10.2337/diabetes.47.4.544

Add to Selected Citations
You have accessRestricted Access
Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.
K Kishi, N Muromoto, Y Nakaya, I Miyata, A Hagi, H Hayashi and Y Ebina

Diabetes 1998 Apr; 47 (4): 550-558. https://doi.org/10.2337/diabetes.47.4.550

Add to Selected Citations
You have accessRestricted Access
Vascularization of purified pancreatic islet-like cell aggregates (pseudoislets) after syngeneic transplantation.
C Beger, V Cirulli, P Vajkoczy, P A Halban and M D Menger

Diabetes 1998 Apr; 47 (4): 559-565. https://doi.org/10.2337/diabetes.47.4.559

Add to Selected Citations
You have accessRestricted Access
The relationship between humoral and cellular immunity to IA-2 in IDDM.
T M Ellis, D A Schatz, E W Ottendorfer, M S Lan, C Wasserfall, P J Salisbury, J X She, A L Notkins, N K Maclaren and M A Atkinson

Diabetes 1998 Apr; 47 (4): 566-569. https://doi.org/10.2337/diabetes.47.4.566

Add to Selected Citations
You have accessRestricted Access
The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice.
L Liang, E Beshay and G J Prud'homme

Diabetes 1998 Apr; 47 (4): 570-575. https://doi.org/10.2337/diabetes.47.4.570

Add to Selected Citations
You have accessRestricted Access
Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein.
H S Jun, Y Kang, H S Yoon, K H Kim, A L Notkins and J W Yoon

Diabetes 1998 Apr; 47 (4): 576-582. https://doi.org/10.2337/diabetes.47.4.576

Add to Selected Citations
You have accessRestricted Access
Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
G Kwon, J A Corbett, S Hauser, J R Hill, J Turk and M L McDaniel

Diabetes 1998 Apr; 47 (4): 583-591. https://doi.org/10.2337/diabetes.47.4.583

Add to Selected Citations
You have accessRestricted Access
GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
J Dittler, D Seidel, M Schenker and A G Ziegler

Diabetes 1998 Apr; 47 (4): 592-597. https://doi.org/10.2337/diabetes.47.4.592

Add to Selected Citations
You have accessRestricted Access
Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
T Hansen, S M Echwald, L Hansen, A M Møller, K Almind, J O Clausen, S A Urhammer, H Inoue, J Ferrer, J Bryan, L Aguilar-Bryan, M A Permutt and O Pedersen

Diabetes 1998 Apr; 47 (4): 598-605. https://doi.org/10.2337/diabetes.47.4.598

Add to Selected Citations
You have accessRestricted Access
Differentiation between glucose-induced desensitization of insulin secretion and beta-cell exhaustion in the HIT-T15 cell line.
E D Kilpatrick and R P Robertson

Diabetes 1998 Apr; 47 (4): 606-611. https://doi.org/10.2337/diabetes.47.4.606

Add to Selected Citations
You have accessRestricted Access
Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
G M Castillo, J A Cummings, W Yang, M E Judge, M J Sheardown, K Rimvall, J B Hansen and A D Snow

Diabetes 1998 Apr; 47 (4): 612-620. https://doi.org/10.2337/diabetes.47.4.612

Add to Selected Citations
You have accessRestricted Access
Creation and characterization of a mitochondrial DNA-depleted pancreatic beta-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas.
K Tsuruzoe, E Araki, N Furukawa, T Shirotani, K Matsumoto, K Kaneko, H Motoshima, K Yoshizato, A Shirakami, H Kishikawa, J Miyazaki and M Shichiri

Diabetes 1998 Apr; 47 (4): 621-631. https://doi.org/10.2337/diabetes.47.4.621

Add to Selected Citations
You have accessRestricted Access
Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
L A Scrocchi, B A Marshall, S M Cook, P L Brubaker and D J Drucker

Diabetes 1998 Apr; 47 (4): 632-639. https://doi.org/10.2337/diabetes.47.4.632

Add to Selected Citations
You have accessRestricted Access
Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
S E Kahn, C B Verchere, S Andrikopoulos, P J Asberry, D L Leonetti, P W Wahl, E J Boyko, R S Schwartz, L Newell-Morris and W Y Fujimoto

Diabetes 1998 Apr; 47 (4): 640-645. https://doi.org/10.2337/diabetes.47.4.640

Add to Selected Citations
You have accessRestricted Access
Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
D Flamez, A Van Breusegem, L A Scrocchi, E Quartier, D Pipeleers, D J Drucker and F Schuit

Diabetes 1998 Apr; 47 (4): 646-652. https://doi.org/10.2337/diabetes.47.4.646

Add to Selected Citations
You have accessRestricted Access
Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats.
S Higashi, A C Clermont, V Dhir and S E Bursell

Diabetes 1998 Apr; 47 (4): 653-659. https://doi.org/10.2337/diabetes.47.4.653

Add to Selected Citations
You have accessRestricted Access
Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.
C Ferri, G Desideri, R Baldoncini, C Bellini, C De Angelis, C Mazzocchi and A Santucci

Diabetes 1998 Apr; 47 (4): 660-667. https://doi.org/10.2337/diabetes.47.4.660

Add to Selected Citations
You have accessRestricted Access
Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells.
T Babazono, J Kapor-Drezgic, J A Dlugosz and C Whiteside

Diabetes 1998 Apr; 47 (4): 668-676. https://doi.org/10.2337/diabetes.47.4.668

Add to Selected Citations
You have accessRestricted Access
Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro.
P Wentzel and U J Eriksson

Diabetes 1998 Apr; 47 (4): 677-684. https://doi.org/10.2337/diabetes.47.4.677

Add to Selected Citations
You have accessRestricted Access
Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects.
G Argyropoulos, A M Brown, R Peterson, C E Likes, D K Watson and W T Garvey

Diabetes 1998 Apr; 47 (4): 685-687. https://doi.org/10.2337/diabetes.47.4.685

Add to Selected Citations
You have accessRestricted Access
Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.
G A Hitman, N Mannan, M F McDermott, E Aganna, B W Ogunkolade, C N Hales and B J Boucher

Diabetes 1998 Apr; 47 (4): 688-690. https://doi.org/10.2337/diabetes.47.4.688

Add to Selected Citations
You have accessRestricted Access
BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones.
S C Souza, M T Yamamoto, M D Franciosa, P Lien and A S Greenberg

Diabetes 1998 Apr; 47 (4): 691-695. https://doi.org/10.2337/diabetes.47.4.691

Add to Selected Citations